Gatwick Airport’s largest carrier easyJet is expecting to run its full schedule during the busy half-term period despite ...

The town of Clifton Park is considering a ban on e-bikes in parks and nature trails, sparking confusion and debate among ...

Tiffany Slaton is speaking out after a dangerous fall caused her to spend three weeks in the brutal wilderness. She was later found alive in a cabin after the owner of a remote mountain resort ...

A 70-year old tricycle driver was killed and three people were injured after a bus hit his vehicle in Siaton, Negros Oriental ...

Three persons were confirmed dead in a vehicular accident involving an oil tanker and a tricycle in New Washington town, ...

Last year’s Trike-A-Thon raised roughly $15,000. This year’s ended up raising more than $23,000. ELV Director Mary Ramey ...

This is the end of my journey South,' says Yves de Preux (Kino Yves), who has just completed a three-and-a-half year journey on the road, from France to the Southernmost point of Africa.

GT Biopharma (NASDAQ: GTBP) just initiated the dosing in Cohort 2 of its Phase 1 dose escalation trial evaluating GTB-3650 for the treatment of relapsed or refractory (r/r) CD33 expressing hematologic ...

PHILADELPHIA (WPVI) -- A motorcyclist was killed in a crash in Philadelphia's Kensington neighborhood. Police were called to ...

Investing.com — GT Biopharma, Inc. (NASDAQ: GTBP )，一家市值为566万美元的临床阶段生物制药公司，宣布在其GTB-3650的1期剂量递增试验中，成功完成首个队列的安全性评估后，已进入第2队列阶段。根据 InvestingPro ...

Following the formal safety review of Cohort 1, no safety or tolerability issues were observed, allowing the company to move forward with Cohort 2. The company plans on releasing more detailed results ...

GTBP announces completion of dosing in Cohort 1 and start of dosing in Cohort 2 of Phase 1 trial for GTB-3650, showing ...